| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.8M | -29.2% |
| R&D Expense | $82.2M | +5.6% |
| SG&A Expense | $41.3M | +6.2% |
| Operating Income | -$114.8M | -10.0% |
| Net Income | -$104.7M | -3.6% |
| EPS (Basic) | -$2.38 | +8.5% |
| EPS (Diluted) | -$2.38 | +8.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $191.4M | +68.6% |
| Current Assets | $215.3M | -11.8% |
| Total Assets | $228.3M | -10.8% |
| Current Liabilities | $30.8M | -1.8% |
| Total Liabilities | $68.8M | -3.4% |
| Stockholders' Equity | $159.6M | -13.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.1M | -154.4% |
| Capital Expenditures | $1.6M | -59.2% |
| Investing Cash Flow | $105.9M | +330.9% |
| Financing Cash Flow | $53.0M | +14.2% |
| Free Cash Flow | -$82.7M | -130.8% |